| Literature DB >> 27430889 |
Abstract
Lysosomes are the major organelles that carry out degradation functions. They integrate and digest materials compartmentalized by endocytosis, phagocytosis or autophagy. In addition to more than 60 hydrolases residing in the lysosomes, there are also ion channels and transporters that mediate the flux or transport of H(+), Ca(2+), Na(+), K(+), and Cl(-) across the lysosomal membranes. Defects in ionic exchange can lead to abnormal lysosome morphology, defective vesicle trafficking, impaired autophagy, and diseases such as neurodegeneration and lysosomal storage disorders. The latter are characterized by incomplete lysosomal digestion and accumulation of toxic materials inside enlarged intracellular vacuoles. In addition to degradation, recent studies have revealed the roles of lysosomes in metabolic pathways through kinases such as mechanistic target of rapamycin (mTOR) and transcriptional regulation through calcium signaling molecules such as transcription factor EB (TFEB) and calcineurin. Owing to the development of new approaches including genetically encoded fluorescence probes and whole endolysosomal patch clamp recording techniques, studies on lysosomal ion channels have made remarkable progress in recent years. In this review, we will focus on the current knowledge of lysosome-resident ion channels and transporters, discuss their roles in maintaining lysosomal function, and evaluate how their dysfunction can result in disease.Entities:
Keywords: calcium; ion homeostasis; lysosomal storage disease (LSD); lysosome acidification
Mesh:
Substances:
Year: 2016 PMID: 27430889 PMCID: PMC5147046 DOI: 10.1007/s11427-016-5090-x
Source DB: PubMed Journal: Sci China Life Sci ISSN: 1674-7305 Impact factor: 6.038
Digestive enzymes in lysosomes
| Name | pH optimum | Related disease | Reference |
|---|---|---|---|
| beta-Galactosidase-1/GLB1 | 3.5 | GM1-gangliosidosis & Morquio B syndrome | ( |
| beta-Glucuronidase/GUSB | 3.5 | mucopolysaccharidosis type VII | ( |
| alpha-L-iduronidase/IDUA | 3.5 | mucopolysaccharidosis type I | ( |
| Napsin A | 3.5 | – | ( |
| Cathepsin D | 3.5 | – | ( |
| Cathepsin X/Z/P | 3.5 | – | ( |
| Chitobiase/CTBS | 3.5 | – | ( |
| alpha-Galactosidase A/GLA (rhGLA) | 4 | Fabry | ( |
| a-N-acetylgalactosaminidase/NAGA | 4 | Schindler’s disease | ( |
| Heparanase | 4 | – | ( |
| Human hyaluronidase 1/HYAL1 | 4 | mucopolysaccharidosis type IX | ( |
| GM1-beta-galactosidase | 4 | gangliondosis | ( |
| β-Galactocerebrosidase | 4 | Krabbe | ( |
| Legumain/Asparaginyl endopeptidase | 4 | – | ( |
| Galactosylceramidase/GALC | 4.5 | Krabbe’s Disease | ( |
| alpha-N-acetylglucosaminidase/NAGLU | 4.5 | Sanfilippo syndrome B | ( |
| alpha-L-fucosidase/FUCA1 | 4.5 | fucosidosis | ( |
| Hexosaminidase A/HEXA | 4.5 | Tay-Sachs disease | ( |
| Human hyaluronidase 4/HYAL4 | 4.5 | – | ( |
| alpha-Glucosidase/GAA | 4.5 | Pompe’s disease | ( |
| sialidase | 4.5 | Sialidosis | ( |
| Cathepsin S | 4.5 | – | ( |
| Arylsulfatase A/ARSA | 4.5 | metachromatic leukodystrophy (MLD) | ( |
| Sphingomyelinase | 5 | Niemann Pick | ( |
| Iduronate 2-sulfatase | 5 | mucopolysaccharidosis II | ( |
| Glucosamine (N-acetyl)-6-sulfatase | 5 | mucopolysaccharidosis type IIID | ( |
| N-acetylgalactosamine-6-sulfatase | 5 | mucopolysaccharidosis type IVA | ( |
| Hexosaminidase B/HEXB | 5.5 | Sandhoff disease | ( |
| Klotho | 5.5 | – | ( |
| CathepsinA | 5.5 | – | ( |
| Cathepsin V | 5.5 | – | ( |
| Arylsulfatase G/ARSG | 5.5 | mucopolysaccharidosis (in mice) | ( |
| Sulfamidase | 5.5 | mucopolysaccharidosis type IIIA | ( |
| Glucosylceramidase/GBA | 6 | Gaucher disease | ( |
| Acid ceramidase | 6 | Farber | ( |
| Chitotriosidase/CHIT1 | 6 | – | ( |
| Cathepsin B | 6 | – | ( |
| Cathepsin C | 6 | – | ( |
| Cathepsin L | 6 | – | ( |
| Cathepsin O | 6 | – | ( |
| Cathepsin H | 6.5 | – | ( |
| Cathepsin K | 6.5 | – | ( |
| Arylsulfatase B/ARSB | 6.5 | mucopolysaccharidosis Type VI | ( |
| AMSH/STAMBP | 7.2 | – | ( |
| beta-Glucosidase/GBA3 | 5~7 | – | ( |
| Cathepsin E | 3~7 | – | ( |
| Cathepsin F | 5.5~6.5 | – | ( |
| Lysosomal acid lipase | 4 | Wolman disease | ( |
Figure 1Ion channels and ion transporters on the lysosomal membrane. Both identified and putative players are included. Arrows indicate the direction of ion fluxes. V-ATPase is the proton pump that acidifies lysosome. Confirmed lysosomal channels and transporters include non-selective cation channels (TRPML and P2X4) voltage-gated Ca2+ channels (VGCC), two-pore channels (TPC) that are permeable to H+, Ca2+, Na+, SLC38 transporters that co-transport Na+ and amino acids (SLC38A7 and SLC38A9), ClC transporters that exchange cytosolic Cl− for lysosomal H+ (ClC-6 and ClC-7), K+ channels (BK and TMEM175). Putative lysosomal ion transporters include Na+/H+ exchangers (NHE3, NHE5 and NHE6) and Ca2+ pump or Ca2+/H+ exchanger that mediates lysosomal uptake of Ca2+ from the cytosol.
Figure 2Cooperation of ion channels/transporters in regulation of ion homeostasis. A, Regulation of H+ homeostasis by V-ATPase, TPCs and ClC-7. V-ATPase acidifies the lysosomes by pumping H+ into lysosome lumen. This also hyperpolarizes the lysosomal membrane. The hyperpolarization is countered by (i) TPCs, which release Na+ from the lysosomes and (ii) ClC-7, which exchanges two cytosolic Cl for one luminal H+. B, Regulation of Ca2+ homeostasis by putative Ca2+ transporters, VGCCs, non-selective cation channels and TPCs. A putative Ca2+ pump is responsible for lysosomal Ca2+ uptake. Nonselective cation channels (TRPMLs, P2X4), VGCCs and TPCs can release Ca2+ from the lysosome under different conditions. C, Regulation of Na+ homeostasis by TPCs, NHEs and SLC38 transporters, and the effect on metabolism. Na+ accumulates in the lysosomal lumen most likely due to the combined actions of V-ATPase, NHE, and/or Na+/K+-ATPase. The luminal Na+ fuels the Na+-dependent amino acid (AA) transporters, such as SLC38A9, to export AA generated from digestion from lysosomes to the cytosol. AA starvation causes mechanistic target of rapamycin complex 1 (mTORC1) to leave the lysosome. This relieves the blockade of TPCs (Cang et al., 2013), which then dumps Na+ out to halt SLC38 transporters, resulting in AA accumulation inside the lysosome. The gradual buildup of AA at the luminal side eventually leads to reactivation of mTORC1 via SLC38A9 (Wang et al., 2015; Rebsamen et al., 2015; Jung et al., 2015), inactivation of TPCs, AA release and finally autophagy termination. D, Positive feedback reinforcement of TRPML1-mediated lysosomal Ca2+ release via BK channels. Ca2+/Na+ efflux through TRPML1 leads to lysosomal membrane depolarization, which lowers the driving force for continued Ca2+ release. The activation of BK by depolarization and the cytosolic Ca2+ signal generated by TRPML1 causes K+ inflow to the lysosome and hyperpolarization, allowing continued Ca2+ release through the open TRPML.
Figure 3Different pH optima of lysosomal Ca2+-permeable channels. For channels that mediate Ca2+ release from the lysosomes, TRPML1 works optimally in acidic pH, TRPML3 and P2X4 works best at neutral pH, TPCs can work in a broad pH range.
Figure 4Regulation of cellular Fe2+ homeostasis by ferritin and TRPML1. In the cytosol, Fe2+ is stored in complex with ferritin. Nuclear Receptor Coactivator 4 (NCOA4) mediates ferritin trafficking to autophagosomes, which then fuse with lysosomes to allow degradation of ferritin and free Fe2+ from the bound state. Subsequently, TRPML1 mediates Fe2+ efflux from the lysosome to the cytosol.